NeuBase Therapeutics Inc.(NBSE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NBSE NeuBase Therapeutics Inc.

Pre-Market Trading 04-29 09:24:08 EDT

0.4396

-0.0024

-0.54%

盘前0.4390

+0.0140+3.29%

06:33 EDT

High0.4500	Low0.4120	Vol72.17K
Open0.4300	D1 Closing0.4420	Amplitude8.60%
Mkt Cap1.65M	Tradable Cap1.46M	Total Shares3.75M
T/O31.05K	T/O Rate2.17%	Tradable Shares3.32M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"NBSE","market":"US","secType":"STK","nameCN":"NeuBase Therapeutics Inc.","latestPrice":0.4396,"timestamp":1714161600000,"preClose":0.442,"halted":0,"volume":72170,"hourTrading":{"tag":"盘前","latestPrice":0.439,"preClose":0.425,"latestTime":"06:33 EDT","volume":100,"amount":43.9,"timestamp":1714386804514},"delay":0,"floatShares":3320901,"shares":3751590,"eps":-15.008684,"marketStatus":"Pre-Market Trading","change":-0.0024,"latestTime":"04-29 09:24:08 EDT","open":0.43,"high":0.45,"low":0.412,"amount":31053.9224884,"amplitude":0.085973,"askPrice":0.5707,"askSize":300,"bidPrice":0.2924,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-15.008684,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1714397400000},"marketStatusCode":1,"adr":0,"listingDate":1371096000000,"exchange":"NASDAQ","adjPreClose":0.425,"preHourTrading":{"tag":"盘前","latestPrice":0.439,"preClose":0.425,"latestTime":"06:33 EDT","volume":100,"amount":43.9,"timestamp":1714386804514},"postHourTrading":{"tag":"盘后","latestPrice":0.4396,"preClose":0.4396,"latestTime":"17:01 EDT","volume":4,"amount":1.7782,"timestamp":1714165278098},"volumeRatio":1.025255636351775},"requestUrl":"/m/hq/s/NBSE","defaultTab":"news","newsList":[{"id":"2422641716","title":"VERI, CHEK and CZOO among mid-day movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2422641716","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2422641716?lang=en_us&edition=fundamental","pubTime":"2024-03-27 00:55","pubTimestamp":1711472148,"startTime":"0","endTime":"0","summary":"Gainers: Mesoblast Ltd  +74%. Stoke Therapeutics  +70%. Cazoo Group Ltd  +47%. Trump Media & Technology Group Corp.  +43%. Nuvation Bio  +31%. Krispy Kreme  +28%. C3is  +24%. Veritone  +25%. Check-Cap Ltd  +25%.  Reviva Pharmaceuticals Holdings  +24%.  Losers: Quhuo Ltd  -55%. NeuBase Therapeutics  -54%. Ampio Pharmaceuticals  -53%. AppTech Payments Corp  -41%. Cardlytics  -30%. M-tron Industries  -29%. GDS Holdings Limited  -24%. flyExclusive  -24%. Syntec Optics Holdings  -22%. Equillium  -21%.   More on Mid-day movers & stocks.  Veritone: Not An AI Stock To Bank On Veritone, Inc.  Q4 2023 Earnings Call Transcript Check-Cap jumps on Nobul AI business combination Veritone Non-GAAP EPS of -$0.16 in-line, revenue of $34.2M beats by $0.4M Seeking Alpha’s Quant Rating on Check-Cap","market":"hk","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4083881-veri-chek-and-czoo-among-mid-day-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2422192306","title":"Nasdaq Gains Over 50 Points; US Durable Goods Orders Rise In February","url":"https://stock-news.laohu8.com/highlight/detail?id=2422192306","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2422192306?lang=en_us&edition=fundamental","pubTime":"2024-03-26 22:09","pubTimestamp":1711462177,"startTime":"0","endTime":"0","summary":"U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 50 points on Tuesday.\n\nThe Dow traded up 0.08% to 39,346.40 while the NASDAQ rose 0.39% to 16,448.92. The S&amp;P 500 also fell, dropping, 0.23% to 5,230.19.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/03/37936513/nasdaq-gains-over-50-points-us-durable-goods-orders-rise-in-february","is_publish_highlight":false,"gpt_icon":0},{"id":"2422616722","title":"NeuBase Therapeutics, ABVC BioPharma, Stoke Therapeutics among healthcare movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2422616722","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2422616722?lang=en_us&edition=fundamental","pubTime":"2024-03-26 22:00","pubTimestamp":1711461612,"startTime":"0","endTime":"0","summary":"Gainers: Stoke Therapeutics STOK +79%. Mesoblast ADR MESO +29%. ABVC BioPharma  +31%. Praxis Precision Medicines PRAX +25%. Check-Cap CHEK +23%.  Losers: NeuBase Therapeutics  -54%. Ampio Pharmaceuticals AMPE -51%. Tivic Health Systems TIVC -12%. Bluebird bio BLUE -13%. eFFECTOR Therapeutics EFTR -15%.  S&P 500 Health Care Sector +0.2% to 1697.44. Health Care Equipment & Services +0.34% to 1979.48. Pharmaceuticals, Biotechnology & Life Science which contributes 58% to index is +0.05% to 1385.07.  More on Health Care Select Sector SPDR  XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Johnson & Johnson, Boston Scientific least shorted stocks in S&P 500 healthcare sector for Feb-end Waters, Moderna most shorted stocks in S&P 500 health sector till Jan-end Seeking Alpha’s Quant Rating on Health Care Select Sector SPDR","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4083716-neubase-therapeutics-abvc-biopharma-stoke-therapeutics-among-healthcare-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2422694425","title":"GOEV, NBSE and FLGC among pre-market losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2422694425","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2422694425?lang=en_us&edition=fundamental","pubTime":"2024-03-26 20:15","pubTimestamp":1711455352,"startTime":"0","endTime":"0","summary":"Losers: NeuBase Therapeutics  -58%. AppTech Payments Corp  -41% announces proposed underwritten public offering. Ampio Pharmaceuticals  -38% announces voluntary delisting and SEC deregistration. Tivic Health Systems  -16% after Q3 earnings release. Cardlytics  -12% on proposed $150M convertible notes offering. Dada Nexus Ltd  -11% after Q4 earnings release.  eFFECTOR Therapeutics  -8% after Q4 earnings release. Bioline Rx Ltd  -8% after FY earnings release. MAIA Biotechnology  -7% looks to raise $1.33M through a private placement. Global Mofy Metaverse Ltd  -7%. MicroAlgo  -7%. Canoo  -6%. Flora Growth Corp  -5%. Bluebird bio  -5% reports Q4 results.   More on Pre-market losers & stocks.  Canoo: Positive News Isn't Enough Canoo: Avoid After Reverse Stock Split Canoo: There Is A Glimpse Of Hope But Hold Canoo completes acquisition of manufacturing assets from Arrival Canoo's manufacturing facility gets foreign trade zone status; shares rise ~59%","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4083646-goev-nbse-and-flgc-among-pre-market-losers","is_publish_highlight":false,"gpt_icon":0},{"id":"2392743759","title":"North American Morning Briefing: S&P 500 Eyes Record High as Rate Cut Hopes Underpin Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=2392743759","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2392743759?lang=en_us&edition=fundamental","pubTime":"2023-12-19 19:00","pubTimestamp":1702983600,"startTime":"0","endTime":"0","summary":"- The Office Market Had It Hard in 2023. Next Year Looks Worse.- Bank of Japan Chief, Bucking Expectations, Avoids Talk of Rate Increase. Stock futures hovered on Tuesday as investors continued to revel in an expected loosening of monetary policy in 2024 amid a 'soft landing' for the economy.Some Fed officials in recent days appeared to push back against the market's hopes for lower borrowing costs as early as March, but equity investors seem to have shrugged off those comments, for now.Meanwhile, the Bank of Japan reminded traders that an important spigot of cheap money still remains open.The BOJ left its main interest rate at minus 0.1%, and in the accompanying news conference, Governor Ueda provided little evidence he was minded to exit the central bank's ultra-loose monetary policy anytime soon, despite inflation running above its 2% target for 19 consecutive months.Plug Power was downgraded to Underweight from Neutral at Piper Sandler and the price target on shares of the clean en","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neubasetherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0223},{"period":"1month","weight":0.0113},{"period":"3month","weight":-0.3028},{"period":"6month","weight":-0.2673},{"period":"1year","weight":-0.8335},{"period":"ytd","weight":-0.406}],"compareEarnings":[{"period":"1week","weight":0.0265},{"period":"1month","weight":-0.0285},{"period":"3month","weight":0.0428},{"period":"6month","weight":0.2376},{"period":"1year","weight":0.2324},{"period":"ytd","weight":0.0693}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"NeuBase Therapeutics, Inc., a preclinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders, and cancer and oncology applications. Its pipeline includes NT0100 for Huntington's disease; NT0200 for myotonic dystrophy type 1; and NT0300 treatment targets the mutated KRAS gene. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania.","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":-0.051606},{"month":2,"riseRate":0.545455,"avgChangeRate":-0.020666},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.134531},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.102973},{"month":5,"riseRate":0.3,"avgChangeRate":0.003455},{"month":6,"riseRate":0.6,"avgChangeRate":-0.031792},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.023409},{"month":8,"riseRate":0.454545,"avgChangeRate":-0.042752},{"month":9,"riseRate":0.181818,"avgChangeRate":-0.04774},{"month":10,"riseRate":0.545455,"avgChangeRate":-0.044715},{"month":11,"riseRate":0.545455,"avgChangeRate":0.112293},{"month":12,"riseRate":0.363636,"avgChangeRate":0.020535}],"exchange":"NASDAQ","name":"NeuBase Therapeutics Inc.","nameEN":"NeuBase Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NeuBase Therapeutics Inc.(NBSE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest NeuBase Therapeutics Inc.(NBSE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"NeuBase Therapeutics Inc.,NBSE,NeuBase Therapeutics Inc.股票,NeuBase Therapeutics Inc.股票老虎,NeuBase Therapeutics Inc.股票老虎国际,NeuBase Therapeutics Inc.行情,NeuBase Therapeutics Inc.股票行情,NeuBase Therapeutics Inc.股价,NeuBase Therapeutics Inc.股市,NeuBase Therapeutics Inc.股票价格,NeuBase Therapeutics Inc.股票交易,NeuBase Therapeutics Inc.股票购买,NeuBase Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NeuBase Therapeutics Inc.(NBSE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest NeuBase Therapeutics Inc.(NBSE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction